PACTR201311000711179已完成未知
Enterosorbent Intervention Therapies for Populations at risk of Aflatoxin-Related Diseases: Safety evaluation of Unifrom Particle NovaSil in Children (Phase I)
oguchi Memorial Institute for Medical Research0 个研究点目标入组 75 人开始时间: 2013年11月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 3 Year(s) 至 9 Year(s)（—）
- 性别
- All
入选标准
- •1)Healthy (based on physical examinations)
- •2)No history of chronic illness
- •3)No use of prescribed medications for chronic or acute illness
- •4)Normal urinalysis (protein, glucose and bilirubin) using chemstrip
- •5)Normal hemoglobin level (greater than 10g/dl)
- •6)The parent or guardian must sign or thumb print the consent form.
排除标准
- •1)Those not meeting the inclusion criteria
- •2)Abnormal hemoglobin level (below 10g/dl).
研究者
相似试验
招募中
不适用
Optimization of therapy strategies for intestinal failureK91.2K90.9Postsurgical malabsorption, not elsewhere classifiedIntestinal malabsorption, unspecifiedDRKS00021085niversitätsmedizin RostockAbteilung für Gastroenterologie, Endokrinologie und Stoffwechselkrankheiten100
撤回
不适用
Clinical trial for amelioration of bowel uptake in PET/CTNeoplasmsKCT0001162Seoul National University Bundang Hospital300
进行中（未招募）
不适用
Preventive measures and therapies for back painslow back pain, neck pain and postureM54.5M54.2G11.427.695RBR-78bq5xMaria das Graças Rodrigues de Araújo
进行中（未招募）
不适用
A Treatment Protocol for Patients with Gastrointestinal Stromal Tumor who are Ineligible for Participation in Other SU011248 Protocols AND are Refractory to or Intolerant of Imatinib Mesylate.Gastro-intestinal Stromal TumorsMedDRA version: 14.1Level: PTClassification code 10051066Term: Gastrointestinal stromal tumourSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2004-001860-27-ITPFIZER1,098
已完成
不适用
Rational use of substrate reduction therapy and enzyme replacement therapy in patients with type I Gaucher disease (Uso racional de los tratamientos por inhibición de sustrato y enzimático sustitutivo en pacientes con enfermedad de Gaucher tipo I)Type I Gaucher?s diseaseNutritional, Metabolic, EndocrineDisorders of sphingolipid metabolism and other lipid storage disordersISRCTN05147495Aragon Institute of Health Sciences [Instituto Aragonés de Ciencias de la Salud] (Spain)40